Skip to content
Open access

Epidemiological patterns and clinical outcomes of meningitis in Rio de Janeiro in 2025

Oct 2026 · ANPAbstract_CBN26 · 0 citations

Abstract

Background: Meningitis remains a major public health concern, linked to high morbidity and mortality, especially in vulnerable populations. Despite scientific and biotechnological advances, disparities in case distribution and outcomes persist. Data analysis is essential to understand current epidemiological patterns, identify high-risk groups, and guide targeted public health policies. In this context, this study aims to examine confirmed meningitis cases in the state of Rio de Janeiro in 2025, exploring their evolution and potential patterns. Objective: Analyze the clinical course of meningitis cases in Rio de Janeiro in 2025, identifying gaps and epidemiological patterns to assess the effectiveness of healthcare delivery. Methods: It's a analytical situational epidemiological study , based on data from the SINAN, available via DATASUS (TABNET), about confirmed meningitis cases reported in the state of Rio de Janeiro during 2025. The variables analyzed were etiology, clinical outcome, and municipality of notification. “Unknown/blank” cases were used only for overall description. Proportional comparisons assessed associations between etiology, outcomes, fatality, and regional disparities, interpreted in context of the current literature. Results: The analysis identified 1,050 cases, including 183 deaths from the disease, 68 from other causes, and 135 with unknown outcomes. Viral meningitis predominated (28%) and had mostly favorable outcomes, consistent with its generally benign and self-limiting nature. In contrast, pneumococcal (PM), meningococcal (MM), and tuberculous meningitis (TBM) accounted for 50.3% of the deaths, reflecting their greater severity. A high share of unspecified bacterial (BM) and meningitis (UM) cases accounted for 31.5% of state notifications. This indicates diagnostic and surveillance gaps, as the etiologic agent was unknown in ~1/3 of cases, affecting treatment, control measures, and public health response. Overall evaluation showed a 17.3% meningitis fatality rate, markedly higher than expected for a state with Rio de Janeiro’s health system capacity. MM had a 58.3% fatality rate, TBM 36.8%, and PM 28.2%, all well above levels reported in settings with timely diagnosis and treatment. Even viral meningitis, usually considered benign and self-limiting, showed a 4.4% fatality rate, higher than observed where early management is adequate. The high fatality in BM and UM cases, with undefined etiology, reinforces that lack of adequate laboratory diagnosis likely impairs treatment decisions, contributing to worse clinical outcomes. Conclusion: Meningitis in Rio de Janeiro in 2025 was not just an acute infection but a marker of structural inequalities, healthcare gaps, and weak surveillance. The high proportion of cases with undetermined etiology, combined with elevated fatality rates, underscores the urgent need to strengthen laboratory diagnostics, expand primary care coverage, enhance early clinical recognition, and optimize patient management pathways for suspected cases.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.